Key details
Phase
Early testing / Safety & dosing
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Enrollment target
~150 participants
Primary completion
January 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
10 Years – 80 Years
Last updated February 2025